Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

News Go to news feed

Genomma Lab reports lower quarterly profit, sales slightly up

Genomma Lab Internacional reported earnings per share of 0.35 MXN for the quarter ended Sept. 30, 2026, down from 0.440 MXN in the year-ago quarter. Revenue rose 1.27 percent to 4.50 billion MXN from 4.44 billion MXN a year earlier. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Genomma Lab Internacional SAB de CV has already paid €0.0294 in dividends. The last payout was in September.

Financials

In the last quarter, Genomma Lab Internacional SAB de CV had revenue of €206.5M and net profit of €23.64M

(EUR)	September 2026	YoY
Revenue	206.5M	0.45%
Gross profit	126.82M	4.25%
Net profit	23.64M	16.61%
EBITDA	43.44M	4.12%

Fundamentals

Metric	Value
Market capitalization	€753.92M
Number of shares	977.75M
52-week high/low	€0.98 - €0.62
Dividend yield	5.19%
Dividends TTM	€0.0389
Beta	0.14
P/E ratio	9.10
PEG ratio	-2.33
P/B ratio	1.29
P/S ratio	0.90

Company profile

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.